<?xml version="1.0" encoding="UTF-8" ?>
<Rows>
 <Row><RID>00000001</RID> 
 <DATE_OF_BIRTH>1968</DATE_OF_BIRTH> 
 <SEX>F</SEX> 
 <AGE_DIAGNOSIS> 28.0</AGE_DIAGNOSIS> 
 <AGE_OPERATION> 42.0</AGE_OPERATION> 
 <AGE_CURRENT> 51.0</AGE_CURRENT>   
 <HEIGHT> 162.1</HEIGHT> 
 <WEIGHT> 46.1</WEIGHT> 
 <BMI> 17.5</BMI> 
 <BSA> 1.44</BSA> 
 <DIAGNOSIS_NAME>C163.444.00</DIAGNOSIS_NAME> 
 <DIAGNOSIS_DATE>1997-07-10</DIAGNOSIS_DATE> 
 <DIAGNOSIS_DATE_1>1997-07-10</DIAGNOSIS_DATE_1> 
 <DIAGNOSIS_DATE_2>2010-07-21</DIAGNOSIS_DATE_2> 
 <DATE_PREOP_GASTROSCOPY>2011-06-14</DATE_PREOP_GASTROSCOPY> 
 <RESULT_PREOP_GASTROSCOPY>[FINDING]
[Subtotal Gastrectomy]

Premedication (algiron 5mg) 주사 후 10% Lidocaine spray로 인두마취를 하고 위내시경을 시행함.


1) Billroth II operated stomach
2) A &amp; E loop : patent
3) No evidence of intraluminal cancer recurrence
4) mild erythematous anastomotic margin
     easy touch bleeding site  있어 surveillance Bx(G1)
5) marginal reflux gastritis : mild
6) reflux esophagitis : none
7) food stasis (-)
8) other specific finding : discoloration at  body, GC side --&gt; Bx(G2)
    ** EJ junction tone : normalGrossly free.</RESULT_PREOP_GASTROSCOPY> <NUMBER_OF_TUMRS> 1.0</NUMBER_OF_TUMRS>        <POORLY_DIFF_BIOPSY> 1.0</POORLY_DIFF_BIOPSY> <SIGNET_RING_BIOPSY> 1.0</SIGNET_RING_BIOPSY>  <ULCER_GASTROSCOPY> 0.0</ULCER_GASTROSCOPY> <CT_DATE>2011-06-24</CT_DATE> <CT_RESULT>[FINDING]
s&#47;p subtotal gastrectomy, BII

1. T staging : Tx
   Site : Nonvisualized
   Size : Nonvisualized
   Local invasion: not definite
   Direct invasion to adjacent organ: not definite

2. N staging : N 
   Regional lymph nodes with short diameter greater than 8 mm: 0

3. M staging : M 
    distant metastasis: : not definite
    peritoneal carcinomatosis: : not definite

4. Left gastric artery, splenic artery variation: : not definite
Right hepatic artery from SMA

5. Other findings: Uterine myoma.</CT_RESULT> <CT_TSTAGE1>0</CT_TSTAGE1>  <CT_NSTAGE1>99</CT_NSTAGE1>  <CT_MSTAGE1>99</CT_MSTAGE1>  <PETCT_DATE>2011-06-25</PETCT_DATE> <PETCT_RESULT>[FINDING]
PROCEDURE: 
검사 직전에 측정한 환자의 혈당치는 107 mg&#47;dl, 신장 164 cm, 체중 46 kg이었고, F-18 FDG 14 mCi를 Rt. hand에 정맥주사하고 1시간 후에 orbitomeatal line에서 proximal thigh까지의 torso 영상을 얻음.

CLINICAL INFORMATION:
1. Stomach cancer.
2. Op: (1) B-II STG (adenocarcinoma, PD and signet ring cell type, LN 0&#47;37), &apos;93&#47;7; (2) Bx, gastric body (adenocarcinoma, PD, signet ring cell type), &apos;11&#47;6&#47;14.
3. Restaging.

FINDINGS:
Remnant stomach에 diffuse FDG uptake이 있으나, 뚜렷하게 증가된 focal FDG uptake은 보이지 않음.

Lt. parotid area의 superficial portion에 focal FDG uptake이 있음(SUVmax 2.7).
Both upper internal jugular chains, Rt. submandibular area에 mild nodular FDG uptakes이 있음.
Lt. hilum, both peribronchial areas에도 mild nodular FDG uptakes이 있음.

Left breast의 lower mid portion에 focal low density lesion이 있고, PET images에서 perceptible uptake은 없음.

Uterus에 increased activity를 보이는 bulging contour가 있음(SUVmax 2.7).

Lt. shoulder joint 주위에 focal FDG uptake이 관찰됨.

Right lung, LLL에 a few small nodules가 보임.

다른 특이소견 없음.
[CONCLUSION]
1. Biopsy proven recurrent cancer cannot be differentiated from physiologic activity of stomach.
2. Possibly, reactive LN in left parotid area.
   DDx. Salivary gland tumor.
3. Reactive LNs in both upper internal jugular chains, Rt. submandibular area, Lt. pulmonary hilum and both peribronchial areas.
4. Possibly, benign tumor in left breast.
5. Uterine myomas.
6. Periarthritis in Lt. shoulder.
7. A few small nodules of indeterminate clinical significance in right lung and LLL.
[RECOMMENDATION]
Neck &amp; breast US, if clinically needed.</PETCT_RESULT> <OPERATION_DATE>2011-06-29</OPERATION_DATE> <OP_APPROACH> 1.0</OP_APPROACH> <OP_RADICALITY> 0.0</OP_RADICALITY> <OP_RESECTION_EXTENT> 0.0</OP_RESECTION_EXTENT> <OP_LYMPHNODE_DISSECTION> 99.0</OP_LYMPHNODE_DISSECTION> <OP_COMBINED_RESECTION> 99.0</OP_COMBINED_RESECTION> <OP_ANASTOMOSIS> 99.0</OP_ANASTOMOSIS> <ST_STAGE> 99.0</ST_STAGE> <SN_STAGE> 99.0</SN_STAGE> <SM_STAGE> 99.0</SM_STAGE> <s-H> 99.0</s-H> <s-P> 99.0</s-P> <ASCITES>No</ASCITES> <CYTOLOGY>No</CYTOLOGY> <OPERATION_TIME> 175.0</OPERATION_TIME> <BLOOD_LOSS>400</BLOOD_LOSS> <PATHOLOGY_REPORT_DATE>2011-06-29</PATHOLOGY_REPORT_DATE> <PATHOLOGY_NUMBER_OF_TUMOR> 1.0</PATHOLOGY_NUMBER_OF_TUMOR>      <RESECTION_MARGIN_PROXIMAL> 7.5</RESECTION_MARGIN_PROXIMAL> <RESECTION_MARGIN_DISTAL> 18.0</RESECTION_MARGIN_DISTAL> <PATHOLOGY_DEPTH_OF_INVASION> 11.0</PATHOLOGY_DEPTH_OF_INVASION>  <PT_STAGE> 99.0</PT_STAGE> <PN_STAGE> 1.0</PN_STAGE> <PM_STAGE> 0.0</PM_STAGE> <METASTATIC_LYMPHNODE> 00000000000000000000000000000000000013</METASTATIC_LYMPHNODE> <RETRIEVED_LYMPHNODE> 00000000000000000000000000000000000000</RETRIEVED_LYMPHNODE>           <LYMPHNODE_4SB_METASTASIS> 00000000000000000000000000000000000000</LYMPHNODE_4SB_METASTASIS> <LYMPHNODE_4SB_RETRIEVED> 00000000000000000000000000000000000010</LYMPHNODE_4SB_RETRIEVED>                                         <PATHOLOGY_DIFFERENTIATION>7</PATHOLOGY_DIFFERENTIATION>  <LYMPHATIC_INVASION> 99.0</LYMPHATIC_INVASION> <VASCULAR_INVASION> 99.0</VASCULAR_INVASION> <NEURAL_INVASION> 99.0</NEURAL_INVASION>     <LAST_VISIT_DATE>2020-06-08</LAST_VISIT_DATE> <OVERALL_SURVIVAL_LAST_VISIT> 3267.0</OVERALL_SURVIVAL_LAST_VISIT> </Row>
 <Row><RID>00000002</RID> <DATE_OF_BIRTH>1951</DATE_OF_BIRTH> <SEX>M</SEX> <AGE_DIAGNOSIS> 46.0</AGE_DIAGNOSIS> <AGE_OPERATION> 67.0</AGE_OPERATION> <AGE_CURRENT> 69.0</AGE_CURRENT>  <ASA> 2.0</ASA> <HEIGHT> 160.0</HEIGHT> <WEIGHT> 56.0</WEIGHT> <BMI> 21.8</BMI> <BSA> 1.57</BSA> <DIAGNOSIS_NAME>C16.444.00</DIAGNOSIS_NAME> <DIAGNOSIS_DATE>1997-07-10</DIAGNOSIS_DATE> <DIAGNOSIS_DATE_1>1997-07-10</DIAGNOSIS_DATE_1> <DIAGNOSIS_DATE_2>2005-09-01</DIAGNOSIS_DATE_2> <DATE_PREOP_GASTROSCOPY>2018-12-11</DATE_PREOP_GASTROSCOPY> <RESULT_PREOP_GASTROSCOPY>[FINDING]

전처치로 Cimetropium Bromide 5mg, 주입후 에 검사 시행 

# EGD

1) Billroth II operated stomach (1995-09-19)
2) A &amp; E loop : patent
3) Evidence of intraluminal cancer recurrence - Y
4) Food stasis - G0, no residual food 
5) Reflux gastritis - Extent - G2 : up to body                             
                            Redness - G3 : with erosion or ulcer      
                            Bile - B1 : bile  refluxed 

6) reflux esophagitis  : minimal change
7) other specific finding : 
   - gastrojejunostomy anastomosis site, PW, 5cm sized  huge shallow ulcer lesion 
       -&gt; Bx. (G1 x5) 
    - 이전 내시경 검사시 보였던 ulcer, nodular lesion 모두 연결된 것으로 보임. 
    

생검용 포셉 사용함: Yes
스네어 (&gt;5mm 병변) 사용함: No  

- no immediate complication
- 검사 종료 후 통증 사정: 통증(무)
- 내시경소견과 조직검사시 부위는 PACS참조</RESULT_PREOP_GASTROSCOPY> <NUMBER_OF_TUMRS> 1.0</NUMBER_OF_TUMRS>  <LOCATION_VERTICAL_GASTROSCOPY> 1.0</LOCATION_VERTICAL_GASTROSCOPY> <LOCATION_HORIZONTAL_GASTROSCOPY> 99.0</LOCATION_HORIZONTAL_GASTROSCOPY>       <POORLY_COHESIVE_BIOPSY> 1.0</POORLY_COHESIVE_BIOPSY> <ULCER_GASTROSCOPY> 0.0</ULCER_GASTROSCOPY> <CT_DATE>2018-11-30</CT_DATE> <CT_RESULT>[FINDING]
1.       T staging: T( 1) 

-                       Site: enhancing wall thickening near the G-J anastomotic site

2.       N staging: N(0)

-                       단경이 8mm 이상인 regional LN 수; 없음. 
                     
3.       M staging: M( 0)

-                       distant metastasis (-)
-                       peritoneal carcinomatosis (-)

4.       Lt gastric artery, splenic artery variation 여부 확인;
                       None
5.       Other findings
                       Few tiny hepatic low densities at the S7 and S8, suggesting small hepatic cysts. 
                        Mild CBD dilatation suggesting due to STG.
[CONCLUSION]
Stomach Ca. near the G-J anastomotic site of prev. STG, suggesting T1 or T2 N0. 
Few tiny hepatic low densities at the S7 and S8, suggesting small hepatic cysts.</CT_RESULT> <CT_TSTAGE1>10</CT_TSTAGE1>  <CT_NSTAGE1>00</CT_NSTAGE1>  <CT_MSTAGE1>0</CT_MSTAGE1>    <OPERATION_DATE>2019-01-03</OPERATION_DATE> <OP_APPROACH> 0.0</OP_APPROACH> <OP_RADICALITY> 0.0</OP_RADICALITY> <OP_RESECTION_EXTENT> 0.0</OP_RESECTION_EXTENT> <OP_LYMPHNODE_DISSECTION> 2.0</OP_LYMPHNODE_DISSECTION> <OP_COMBINED_RESECTION> 99.0</OP_COMBINED_RESECTION> <OP_ANASTOMOSIS> 2.0</OP_ANASTOMOSIS> <ST_STAGE> 2.0</ST_STAGE> <SN_STAGE> 1.0</SN_STAGE> <SM_STAGE> 1.0</SM_STAGE> <s-H> 99.0</s-H> <s-P> 99.0</s-P> <ASCITES>No</ASCITES> <CYTOLOGY>No</CYTOLOGY> <OPERATION_TIME> 250.0</OPERATION_TIME> <BLOOD_LOSS>100</BLOOD_LOSS> <PATHOLOGY_REPORT_DATE>2019-01-03</PATHOLOGY_REPORT_DATE> <PATHOLOGY_NUMBER_OF_TUMOR> 1.0</PATHOLOGY_NUMBER_OF_TUMOR> <TUMOR_SIZE_LONG_DIAMETER> 6.0</TUMOR_SIZE_LONG_DIAMETER> <TUMOR_SIZE_MIN_DIAMETER> 0.8</TUMOR_SIZE_MIN_DIAMETER> <PATHOLOGY_LOCATION_VERTICAL> 1.0</PATHOLOGY_LOCATION_VERTICAL> <PATHOLOGY_LOCATION_HORIZONTAL> 99.0</PATHOLOGY_LOCATION_HORIZONTAL> <GROSS_TYPE_PATHOLOGY> 8.0</GROSS_TYPE_PATHOLOGY> <RESECTION_MARGIN_PROXIMAL> 1.5</RESECTION_MARGIN_PROXIMAL> <RESECTION_MARGIN_DISTAL> 2.6</RESECTION_MARGIN_DISTAL> <PATHOLOGY_DEPTH_OF_INVASION> 9.0</PATHOLOGY_DEPTH_OF_INVASION>  <PT_STAGE> 7.0</PT_STAGE> <PN_STAGE> 2.0</PN_STAGE> <PM_STAGE> 0.0</PM_STAGE> <METASTATIC_LYMPHNODE> 00000000000000000000000000000000000007</METASTATIC_LYMPHNODE> <RETRIEVED_LYMPHNODE> 00000000000000000000000000000000000001</RETRIEVED_LYMPHNODE> <LYMPHNODE_1_METASTASIS> 00000000000000000000000000000000000001</LYMPHNODE_1_METASTASIS> <LYMPHNODE_1_RETRIEVED> 00000000000000000000000000000000000005</LYMPHNODE_1_RETRIEVED> <LYMPHNODE_2_METASTASIS> 00000000000000000000000000000000000000</LYMPHNODE_2_METASTASIS> <LYMPHNODE_2_RETRIEVED> 00000000000000000000000000000000000001</LYMPHNODE_2_RETRIEVED>     <LYMPHNODE_4SA_METASTASIS> 00000000000000000000000000000000000000</LYMPHNODE_4SA_METASTASIS> <LYMPHNODE_4SA_RETRIEVED> 00000000000000000000000000000000000000</LYMPHNODE_4SA_RETRIEVED>                   <LYMPHNODE_10_METASTASIS> 00000000000000000000000000000000000000</LYMPHNODE_10_METASTASIS> <LYMPHNODE_10_RETRIEVED> 00000000000000000000000000000000000001</LYMPHNODE_10_RETRIEVED>                       <PATHOLOGY_DIFFERENTIATION>6</PATHOLOGY_DIFFERENTIATION> <LAUREN_CLASSIFICATION> 1.0</LAUREN_CLASSIFICATION> <LYMPHATIC_INVASION> 0.0</LYMPHATIC_INVASION> <VASCULAR_INVASION> 0.0</VASCULAR_INVASION> <NEURAL_INVASION> 1.0</NEURAL_INVASION>     <LAST_VISIT_DATE>2020-08-24</LAST_VISIT_DATE> <OVERALL_SURVIVAL_LAST_VISIT> 599.0</OVERALL_SURVIVAL_LAST_VISIT> </Row>
</Rows>